Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hays Arnold"'
Autor:
Marlyn J. Mayo, Alan J. Wigg, Barbara A. Leggett, Hays Arnold, Alexander J. Thompson, Martin Weltman, Elizabeth J. Carey, Andrew J. Muir, Lei Ling, Stephen J. Rossi, Alex M. DePaoli
Publikováno v:
Hepatology Communications, Vol 2, Iss 9, Pp 1037-1050 (2018)
Patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodiol have few treatment options. Alkaline phosphatase (ALP) and bilirubin levels correlate with the risk of liver transplant or death in PBC patients. Fibroblast gr
Externí odkaz:
https://doaj.org/article/4cf97fa6121848f28eac1a691058cf71
Autor:
Fred Poordad, Vinod Rustgi, Robert S. Brown, Vishal Patel, Marcelo Kugelmas, Fredric Regenstein, Luis Balart, Douglas LaBrecque, Kimberly Brown, Mark Avila, Michael Biederman, Glenn Freed, Richard Smith, Marc Bernstein, Hays Arnold, Joel Cahan, Scott Fink, William Katkov, Hatef Massoumi, Stephen Harrison
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 8 (2015)
Objectives: Although effective, direct acting antiviral (DAA) therapies for genotype 1 (GT 1) hepatitis C virus (HCV) have been associated with compliance challenges. Additionally, treatment at predominantly community-based centers has been associate
Externí odkaz:
https://doaj.org/article/07697f9d5ed5474a9115123df023bf7f
Autor:
Jonathan Ricker, Scott McNear, Timothy Cassidy, Eric Plott, Hays Arnold, Brian Kendall, Kevin Franklin
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 4 (2011)
Background: Eosinophilic esophagitis (EoE) is a clinicopathologic disorder first described in 1978 which has gained significant recognition over the past 10 years. Numerous prevalence studies have been performed around the globe, both in pediatric an
Externí odkaz:
https://doaj.org/article/af8ace02b0fe4752b576ce5bf628028c
Autor:
Severine Vermeire, Peter L Lakatos, Timothy Ritter, Stephen Hanauer, Brian Bressler, Reena Khanna, Kim Isaacs, Saumin Shah, Alysha Kadva, Helen Tyrrell, Young S Oh, Swati Tole, Akiko Chai, Jennifer Pulley, Christopher Eden, Wenhui Zhang, Brian G Feagan, Philip Abraham, Mauro Acir Crippa Júnior, Humberto Aguilar, Tasneem Ahmed, Istvan Altorjay, Vibeke Andersen, Ronen Arai, Hays Arnold, Karlee Ausk, Jeffrey Axler, Kamran Ayub, Avinash Balekuduru, Guerino Barbalaco Neto, Isaac Bassan, Brian Behm, Pradeep Bekal, Shobna Bhatia, Barnabas Bod, Carlos Eduardo Brandão Mello, Julia Brandeburova, Johannes Breedt, Ivan Chopey, Michael Connor, Richard Corlin, Carlos Alejandro Cortez Hernandez, Arijit De, Alexander de Sá Rolim, Sandra Di Felice Boratto, Tyler Dixon, Debora Dourado Poli, David Dresner, George Aaron Du Vall, Matthias Ebert, Robert Ehehalt, Atilla Ertan, Ruben Escarcega Valencia, Jason Etzel, Jan Fallingborg, Brian Feagan, Miroslav Fedurco, Enrique Fernandez Castro, Valéria Ferreira de Almeida Borges, Mark Finklestein, Andreas Fischer, Mark Fleisher, Angel Ricardo Flores Rendon, Ronald Fogel, Osvaldo Franceschi Junior, Curtis Freedland, David Gatof, Kanwar Gill, Henning Glerup, Vardaraj Gokak, Eran Goldin, Hector Alejandro Gomez Jaramillo, Nitin Gupta, Zoltan Gurzo, Olga Gyrina, Mohammed Aejaz Habeeb, Robert Hardi, William Harlan, Ammar Hemaidan, Melvin Heyman, Peter Hoffmann, William Holderman, Frank Holtkamp-Endemann, Gyula Horvat, Eran Israeli, Sender Jankiel Miszputen, Søren Jensen, Kenneth Johnson, Jennifer Jones, Osvaldo Junior, Barbora Kadleckova, Mukesh Kalla, Zsuzsanna Kallo, Nicholas Karyotakis, Lior Katz, Leo Katz, Nirmal Kaur, Pavel Kohout, Peter Lakatos, Emmanuel Larriva de los Reyes, Robert Lee, Bernard Leman, Olena Levchenko, Henry Levine, Lúcia Libanez Bessa Campelo Braga, Edward Loftus, Tetiana Lohdanidi, Randy Longman, Josefina Lozano, Christian Maaser, Laszlo Madi-Szabo, Everson Fernando Malluta, John Marshall, Francisca Martinez Silva, Kenneth Maynard, Agnieszka Meder, Chetan Mehta, Peter Minarik, Joachim Mueller, Shrikant Mukewar, Bela Nagy, Vasyl Neiko, Markus Neurath, Brian Nichol, James Novick, Nitin Pai, William Pandak, Sarat Panigrahi, Ulrich-Frank Pape, Raymundo Paraná, Nimisha Parekh, Bhaktasharan Patel, Gyula Pecsi, Sergio Peralta, Martin Pesta, Eva Peterfai, Carlo Petruzzellis, Robert Petryka, Roberta Pica, Carlos Piniella, Vijayalakshmi Pratha, Vlastimil Prochazka, Sergey Prokopchuk, Ludmyla Prystupa, Amarender Puri, Tova Rainis, Bhashyakarla Ramesh Kumar, Odery Ramos Júnior, Iaroslava Rishko, Bryan Robbins, Elizabeth Rock, Marcelo Rodrigues Borba, Miguel Rodriguez, Jerzy Rozciecha, Azalia Yuriria Ruiz Flores, Grazyna Rydzewska, Rifaat Safadi, Simone Saibeni, Anja Schirbel, Wolff Schmiegel, Róbert Schnabel, Herbert Schneider, Armando Segui, Jakob Seidelin, Ursula Seidler, Joseph Sellin, Ira Shafran, Aasim Sheikh, Alex Sherman, Haim Shirin, Akash Shukla, Firdous Siddiqui, Robert Sike, Ajit Sood, Andreas Stallmach, Mykola Stanislavchuk, Michael Staun, Daniel Stein, Alon Steinberg, Hillary Steinhart, Jonathas Stifft, Rakesh Tandon, Vishwanath Tantry, Syed Thiwan, Matthias Treiber, Jan Ulbrych, John Valentine, Rajeev Vasudeva, Byron Vaughn, Brenda Velasco, Aron Vincze, Miroslava Volfova, Mattitiahu Waterman, L. Michael Weiss, Elise Wiesner, Alonzo Williams, Thomas Witthoeft, Robert Wohlman, John Wright, Jesus Kazuo Yamamoto Furusho, Ziad Younes, Khurshid Yousuf, Yaroslav Zborivskyy, Stefan Zeuzem, Vyacheslav Zhdan
BACKGROUND: Etrolizumab is a gut-targeted anti-β7 integrin monoclonal antibody. In a previous phase 2 induction study, etrolizumab significantly improved clinical remission versus placebo in patients with moderately to severely active ulcerative col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49028f5b2bacad2d2fd85b64f3d13e76
https://lirias.kuleuven.be/handle/20.500.12942/720387
https://lirias.kuleuven.be/handle/20.500.12942/720387
Autor:
Hays Arnold, Andrew J. Muir, Alexander J. Thompson, Alex M. DePaoli, Lei Ling, Stephen J. Rossi, Alan Wigg, Elizabeth J. Carey, Martin Weltman, Barbara A. Leggett, Marlyn J. Mayo
Publikováno v:
Hepatology Communications, Vol 2, Iss 9, Pp 1037-1050 (2018)
Hepatology Communications
Hepatology Communications
Patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodiol have few treatment options. Alkaline phosphatase (ALP) and bilirubin levels correlate with the risk of liver transplant or death in PBC patients. Fibroblast gr
Autor:
Stephen J. Rossi, Mary E. Rinella, Mark J. Jaros, Alex M. DePaoli, Marcelo Kugelmas, Stephen A. Harrison, Manal F. Abdelmalek, Hays Arnold, James F. Trotter, Mustafa R. Bashir, ing L, Angelo H. Paredes, Rohit Loomba
Publikováno v:
The Lancet. 391:1174-1185
Non-alcoholic steatohepatitis is a chronic liver disease characterised by the presence of hepatic steatosis, inflammation, and hepatocellular injury, for which no Food and Drug Administration (FDA)-approved treatment exists. FGF19 is a hormone that r
Autor:
Stephen H. Caldwell, Saumya Jayakumar, Anna Mae Diehl, G. Mani Subramanian, Ling Han, John G. McHutchison, Zachary Goodman, Nezam H. Afdhal, C. Stephen Djedjos, Eric Lawitz, Parvez S. Mantry, Rohit Loomba, Hays Arnold, Robert P. Myers, Michael Charlton
Publikováno v:
Hepatology. 67:549-559
Inhibition of apoptosis signal-regulating kinase 1, a serine/threonine kinase, leads to improvement in inflammation and fibrosis in animal models of nonalcoholic steatohepatitis. We evaluated the safety and efficacy of selonsertib, a selective inhibi
Autor:
Hays Arnold, Robert P. Myers, Saumya Jayakumar, C. Stephen Djedjos, Michael Charlton, Michael S. Middleton, Magdy Elkhashab, Manal F. Abdelmalek, Parvez S. Mantry, Anna Mae Diehl, Ren Xu, Stephen H. Caldwell, Nezam H. Afdhal, Ling Han, Reem Ghalib, Claude B. Sirlin, Kris V. Kowdley, Rohit Loomba, Eric Lawitz, Zachary Goodman, G. Mani Subramanian
Publikováno v:
Journal of hepatology, vol 70, iss 1
Jayakumar, Saumya; Middleton, Michael S; Lawitz, Eric J; Mantry, Parvez S; Caldwell, Stephen H; Arnold, Hays; et al.(2019). Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. JOURNAL OF HEPATOLOGY, 70(1), 133-141. doi: 10.1016/j.jhep.2018.09.024. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/96b1p0vj
Jayakumar, Saumya; Middleton, Michael S; Lawitz, Eric J; Mantry, Parvez S; Caldwell, Stephen H; Arnold, Hays; et al.(2019). Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. JOURNAL OF HEPATOLOGY, 70(1), 133-141. doi: 10.1016/j.jhep.2018.09.024. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/96b1p0vj
Background & Aims Non-invasive tools for monitoring treatment response and disease progression in non-alcoholic steatohepatitis (NASH) are needed. Our objective was to evaluate the utility of magnetic resonance (MR)-based hepatic imaging measures for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da08a6210691f138234a9000638dd431
https://escholarship.org/uc/item/96b1p0vj
https://escholarship.org/uc/item/96b1p0vj
Autor:
Robert S. Brown, Vishal Patel, Glenn Freed, Richard B. Smith, Marcelo Kugelmas, Fredric Regenstein, Stephen A. Harrison, Mark Avila, Marc Bernstein, Fred Poordad, Douglas R. LaBrecque, Vinod K. Rustgi, Joel Cahan, Luis A. Balart, Kimberly A. Brown, Hays Arnold, Michael Biederman, Scott Fink, Hatef Massoumi, William Katkov
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 8 (2015)
Objectives: Although effective, direct acting antiviral (DAA) therapies for genotype 1 (GT 1) hepatitis C virus (HCV) have been associated with compliance challenges. Additionally, treatment at predominantly community-based centers has been associate
Autor:
Stephen A. Harrison, Mary E. Rinella, Manal F. Abdelmalek, Lei Ling, James F. Trotter, Marcelo Kugelmas, Hays Arnold, Mustafa R. Bashir, Angelo H. Paredes, Alex M. DePaoli, Rohit Loomba, Stephen J. Rossi
Publikováno v:
Journal of Hepatology. 66:S92-S93